Recurrent Islet Cell Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00958 | Carboplatin | 1 | Completed | 1 |
DB15631 | Edodekin alfa | 1 | Completed | 1 |
DB01590 | Everolimus | 1 | Completed | 1 |
DB14123 | Menthol | 1 | Completed | 1 |
DB15721 | Natural Killer Cell | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Completed | 1 |
DB00877 | Sirolimus | 1 | Completed | 1 |
DB06287 | Temsirolimus | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Completed | 1 |
DB04879 | Vatalanib | 1 | Completed | 1 |
DB00361 | Vinorelbine | 1 | Completed | 1 |
DB06589 | Pazopanib | 1 / 2 | Completed | 1 |
DB00853 | Temozolomide | 1 / 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB01101 | Capecitabine | 2 | Active Not Recruiting | 1 |
DB01101 | Capecitabine | 2 | Completed | 1 |
DB05928 | Dovitinib | 2 | Withdrawn | 1 |
DB01590 | Everolimus | 2 | Terminated | 2 |
DB00317 | Gefitinib | 2 | Completed | 1 |
DB14123 | Menthol | 2 | Completed | 1 |
DB08896 | Regorafenib | 2 | Completed | 1 |
DB06176 | Romidepsin | 2 | Terminated | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 2 | Completed | 1 |
DB06287 | Temsirolimus | 2 | Completed | 1 |
DB00135 | Tyrosine | 2 | Withdrawn | 1 |